{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:31:34Z","timestamp":1791271894710,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA123031"],"award-info":[{"award-number":["R01CA123031"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA207083"],"award-info":[{"award-number":["R01CA207083"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA199235"],"award-info":[{"award-number":["U01CA199235"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002322","name":"Schlumberger Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1106401"],"award-info":[{"award-number":["DGE-1106401"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGF-1106401"],"award-info":[{"award-number":["DGF-1106401"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014228","name":"Duke Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.celrep.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T14:46:08Z","timestamp":1500993968000},"page":"999-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution"],"prefix":"10.1016","volume":"20","author":[{"given":"Grace R.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Soderquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorin","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Leeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Stepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer P.","family":"Tingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moiez","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon J.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn J.","family":"McRee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Counter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channing J.","family":"Der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2017.07.006_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/2159-8290.CD-14-1518","article-title":"Clinical acquired resistance to RAF inhibitor combinations in BRAF-mutant colorectal cancer through MAPK pathway alterations","volume":"5","author":"Ahronian","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2017.07.006_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cell.2016.03.045","article-title":"A small molecule RAS-mimetic disrupts RAS association with effector proteins to block signaling","volume":"165","author":"Athuluri-Divakar","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2017.07.006_bib5","doi-asserted-by":"crossref","first-page":"e13978","DOI":"10.1371\/journal.pone.0013978","article-title":"DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset","volume":"5","author":"Berg","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccell.2016.06.022","article-title":"High-throughput phenotyping of lung cancer somatic mutations","volume":"30","author":"Berger","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2012.10.014","article-title":"A missing link in genotype-directed cancer therapy","volume":"151","author":"Bernards","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2017.07.006_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","article-title":"Stable suppression of tumorigenicity by virus-mediated RNA interference","volume":"2","author":"Brummelkamp","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib10","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/0008-5472.CAN-06-3752","article-title":"K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling","volume":"67","author":"Campbell","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/1535-7163.MCT-13-0513","article-title":"Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity","volume":"13","author":"Campbell","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2017.07.006_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/2159-8290.CD-15-0896","article-title":"Oncogenic BRAF deletions that function as homodimers and are sensitive to inhibition by RAF dimer inhibitor LY3009120","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2017.07.006_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2012.11.007","article-title":"Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models","volume":"23","author":"Corcoran","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccell.2014.11.007","article-title":"Measurement of PIP3 levels reveals an unexpected role for p110\u03b2 in early adaptive responses to p110\u03b1-specific inhibitors in luminal breast cancer","volume":"27","author":"Costa","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4161\/sgtp.1.1.12178","article-title":"Ras history: the saga continues","volume":"1","author":"Cox","year":"2010","journal-title":"Small GTPases"},{"key":"10.1016\/j.celrep.2017.07.006_bib18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/1078-0432.CCR-14-2180","article-title":"RAS synthetic lethal screens revisited: still seeking the elusive prize?","volume":"21","author":"Downward","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1172\/JCI57909","article-title":"Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers","volume":"121","author":"Ebi","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2017.07.006_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cas.12383","article-title":"Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancers","volume":"105","author":"Ebi","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.celrep.2017.07.006_bib22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.1890","article-title":"Effective use of\u00a0PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers","volume":"14","author":"Engelman","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2017.07.006_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/2159-8290.CD-11-0106","article-title":"BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors","volume":"1","author":"Faber","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ccell.2016.02.010","article-title":"Activation mechanism of oncogenic deletion mutations in BRAF, EGFR, and HER2","volume":"29","author":"Foster","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2017.07.006_bib27","first-page":"1","article-title":"A review of the evolution of systemic chemotherapy in the management of colorectal cancer","volume":"14","author":"Gustavsson","year":"2015","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.celrep.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.15252\/msb.20145216","article-title":"Measuring error rates in genomic perturbation screens: gold standards for human functional genomics","volume":"10","author":"Hart","year":"2014","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.celrep.2017.07.006_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature07782","article-title":"Tumours with PI3K activation are resistant to dietary restriction","volume":"458","author":"Kalaany","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1158\/2159-8290.CD-15-1377","article-title":"Epithelial-to-mesenchymal transition defines feedback activation of receptor tyrosine kinase signaling induced by MEK inhibition in KRAS-mutant lung cancer","volume":"6","author":"Kitai","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.celrep.2014.07.033","article-title":"RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells","volume":"8","author":"Lamba","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer\u2019s addiction to blocks in apoptosis","volume":"8","author":"Letai","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2017.07.006_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ccr.2005.10.014","article-title":"Reduction in the requirement of oncogenic Ras signaling to activation of PI3K\/AKT pathway during tumor maintenance","volume":"8","author":"Lim","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2017.07.006_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.aad6204","article-title":"Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism","volume":"351","author":"Lito","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature18600","article-title":"A combinatorial strategy for treating KRAS-mutant lung cancer","volume":"534","author":"Manchado","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2017.07.006_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1158\/2159-8290.CD-11-0224","article-title":"Essential gene profiles in breast, pancreatic, and ovarian cancer cells","volume":"2","author":"Marcotte","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib38","doi-asserted-by":"crossref","first-page":"ra121","DOI":"10.1126\/scisignal.aaa1877","article-title":"Systematic identification of signaling pathways with potential to confer anticancer drug resistance","volume":"7","author":"Martz","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2017.07.006_bib39","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1038\/ncomms9305","article-title":"Vertical suppression of the\u00a0EGFR pathway prevents onset of resistance in colorectal cancers","volume":"6","author":"Misale","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2017.07.006_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2015.01.042","article-title":"Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy","volume":"160","author":"Montero","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2014.11.018","article-title":"Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF\/MEK cotargeting but result in melanoma drug addiction","volume":"27","author":"Moriceau","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Ni Chonghaile","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2017.07.006_bib44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2017.07.006_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"Sarosiek","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ccell.2014.11.008","article-title":"Feedback suppression of PI3K\u03b1 signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3K\u03b2","volume":"27","author":"Schwartz","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2017.07.006_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas9","volume":"16","author":"Shalem","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.celrep.2017.07.006_bib50","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1200\/JCO.2015.62.1052","article-title":"Improving prospects for targeting RAS","volume":"33","author":"Singh","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2017.07.006_bib51","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2017.07.006_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.celrep.2014.02.045","article-title":"Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3","volume":"7","author":"Sun","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2017.07.006_bib53","doi-asserted-by":"crossref","first-page":"e38422","DOI":"10.1371\/journal.pone.0038422","article-title":"Histological and molecular evaluation of patient-derived colorectal cancer explants","volume":"7","author":"Uronis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2017.07.006_bib54","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib56","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.aac7041","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2017.07.006_bib57","doi-asserted-by":"crossref","first-page":"ra122","DOI":"10.1126\/scisignal.2005301","article-title":"RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosis","volume":"7","author":"Winter","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2017.07.006_bib58","doi-asserted-by":"crossref","first-page":"rs4","DOI":"10.1126\/scisignal.2002612","article-title":"MicroSCALE screening reveals genetic modifiers of therapeutic response in melanoma","volume":"5","author":"Wood","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2017.07.006_bib59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival","volume":"14","author":"Zhang","year":"2007","journal-title":"Cell Death Differ."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124717309452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124717309452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:09:17Z","timestamp":1761905357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124717309452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2211124717309452"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2017.07.006","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}